Angelalign Technology Inc. (6699.HK) Says a Preliminary European Court Ruling on Certain Software Features Will Have Minimal Impact on Users

Angelalign Technology Inc. (6699.HK), a leading provider of clear aligner products, has recently announced that a ruling by the Unified Patent Court of Düsseldorf, Germany will have minimal impact on its orthodontists and patients. The ruling, which applies to certain European countries, requires Angelalign to temporarily cease the use of certain software functions that automatically update treatment plans. However, the company assures that this will not affect the quality or effectiveness of its products.

Angelalign’s clear aligner products have gained popularity among orthodontists and patients due to their advanced technology and superior results. The company’s innovative software allows for precise treatment planning and customization, resulting in faster and more accurate teeth straightening. The ruling by the Unified Patent Court of Düsseldorf, Germany, which is currently under appeal, only affects a small portion of Angelalign’s software functions and will not impact the overall performance of its products.

The ruling was issued in response to a patent infringement lawsuit filed by a competitor against Angelalign. The court has ordered Angelalign to temporarily cease the use of certain software functions that automatically update treatment plans in Germany, the United Kingdom, France, Italy, and Spain. However, the ruling excludes other European countries and does not affect the company’s operations in other parts of the world.

Despite the ruling, Angelalign remains confident in its ability to continue providing high-quality clear aligner products to its customers. The company has stated that it is working closely with its legal team to appeal the decision and is confident that the ruling will be overturned. In the meantime, Angelalign is committed to finding alternative solutions to ensure minimal disruption to its customers.

The impact of the ruling on orthodontists and patients who use Angelalign’s products is expected to be minimal. The affected software functions are not essential to the overall treatment process and can be manually updated by orthodontists. Patients will continue to receive the same level of care and treatment, and their results will not be compromised.

Angelalign’s commitment to providing the best possible treatment for its patients remains unwavering. The company’s clear aligner products have helped thousands of people achieve their dream smile, and this ruling will not hinder its mission to continue doing so. Angelalign’s dedication to innovation and technology will ensure that its products remain at the forefront of the orthodontic industry.

In addition to its clear aligner products, Angelalign also offers comprehensive training and support to orthodontists who use its products. The company’s team of experts is always available to assist with any questions or concerns, ensuring that orthodontists can continue to provide the best possible care to their patients.

In conclusion, Angelalign Technology Inc. (6699.HK) remains confident in its ability to overcome the recent ruling by the Unified Patent Court of Düsseldorf, Germany. The company’s clear aligner products have revolutionized the orthodontic industry, and this ruling will not hinder its progress. Angelalign is committed to providing the best possible treatment to its patients and will continue to do so with the support of its dedicated team and innovative technology.